Literature DB >> 1628364

Reversal of multidrug resistance by phenothiazines and structurally related compounds.

A Ramu1, N Ramu.   

Abstract

The multidrug-resistance (MDR)-reversal activity of 232 phenothiazines and structurally related compounds was tested in MDR P388 cells. Such activity was found among compounds exhibiting two ring structures (phenyl, cyclopentyl, cyclohexyl, thienyl or 5-norbornen-2-yl but not pyridinyl) linked by a variety of bridge types and possessing a secondary or tertiary amine group. Among 192 such compounds, 31.8% displayed good activity (MDR-reversal ratio, greater than or equal to 10) and 8.3%, outstanding activity (MDR-reversal ratio, greater than or equal to 30). In a subgroup comprising 56 compounds with a carbonyl residue, 4 with sulfuryl residue and 1 with thienyl residue, 42.7% showed good activity and 18%, outstanding activity. The contribution of these residues to the MDR-reversal activity was particularly evident among compounds containing a cyclic tertiary amine. Among 49 such compounds, 51% displayed good activity and 20.4%, outstanding activity, whereas among the 85 compounds lacking such groups, only 31.8% showed good activity and 4.7%, outstanding activity. Enhancement of this activity by the carbonyl group is also obtained when the latter is part of an amide bond of a tertiary amine. As compounds with a carbonyl group located on the rings, on the bridge to the amine group or beyond the amine are efficient MDR reversers, it seems that the exact molecular location of the carbonyl group is not critical for the elicitation of this activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1628364     DOI: 10.1007/bf00686306

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  25 in total

Review 1.  Cationic amphiphilic drugs and phospholipid storage disorder.

Authors:  U P Kodavanti; H M Mehendale
Journal:  Pharmacol Rev       Date:  1990-12       Impact factor: 25.468

Review 2.  Non-chemotherapeutic agents that potentiate chemotherapy efficacy.

Authors:  D J Stewart; W K Evans
Journal:  Cancer Treat Rev       Date:  1989-03       Impact factor: 12.111

3.  The effect of lysosomotropic agents and secretory inhibitors on anthracycline retention and activity in multiple drug-resistant cells.

Authors:  W D Klohs; R W Steinkampf
Journal:  Mol Pharmacol       Date:  1988-08       Impact factor: 4.436

4.  Reversal of multidrug resistance by lipophilic drugs.

Authors:  E Hofsli; J Nissen-Meyer
Journal:  Cancer Res       Date:  1990-07-01       Impact factor: 12.701

5.  Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance.

Authors:  J M Ford; W C Prozialeck; W N Hait
Journal:  Mol Pharmacol       Date:  1989-01       Impact factor: 4.436

6.  Circumvention of adriamycin resistance by dipyridamole analogues: a structure-activity relationship study.

Authors:  N Ramu; A Ramu
Journal:  Int J Cancer       Date:  1989-03-15       Impact factor: 7.396

7.  Doxorubicin resistance in P388 leukemia--evidence for reduced drug influx.

Authors:  A Ramu; H B Pollard; L M Rosario
Journal:  Int J Cancer       Date:  1989-09-15       Impact factor: 7.396

8.  Effect of duration of exposure to verapamil on vincristine activity against multidrug-resistant human leukemic cell lines.

Authors:  C E Cass; A Janowska-Wieczorek; M A Lynch; H Sheinin; A A Hindenburg; W T Beck
Journal:  Cancer Res       Date:  1989-11-01       Impact factor: 12.701

9.  Modification of cytotoxic drug resistance by non-immuno-suppressive cyclosporins.

Authors:  P R Twentyman
Journal:  Br J Cancer       Date:  1988-03       Impact factor: 7.640

10.  Restoration of doxorubicin responsiveness in doxorubicin-resistant P388 murine leukaemia cells.

Authors:  A Ramu; R Spanier; H Rahamimoff; Z Fuks
Journal:  Br J Cancer       Date:  1984-10       Impact factor: 7.640

View more
  11 in total

Review 1.  New insights into the second generation antihistamines.

Authors:  G M Walsh; L Annunziato; N Frossard; K Knol; S Levander; J M Nicolas; M Taglialatela; M D Tharp; J P Tillement; H Timmerman
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Quinolizidinyl derivatives of iminodibenzyl and phenothiazine as multidrug resistance modulators in ovarian cancer cells.

Authors:  Federica Barbieri; Angela Alama; Bruno Tasso; Vito Boido; Cristina Bruzzo; Fabio Sparatore
Journal:  Invest New Drugs       Date:  2003-11       Impact factor: 3.850

3.  Differential effectiveness of a range of novel drug-resistance modulators, relative to verapamil, in influencing vinblastine or teniposide cytotoxicity in human lymphoblastoid CCRF-CEM sublines expressing classic or atypical multidrug resistance.

Authors:  B T Hill; L K Hosking
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

4.  Reversal of multidrug resistance by bis(phenylalkyl)amines and structurally related compounds.

Authors:  A Ramu; N Ramu
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 5.  Multidrug resistance in cancer chemotherapy.

Authors:  N H Patel; M L Rothenberg
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

6.  New high-throughput screening assay to reveal similarities and differences in inhibitory sensitivities of multidrug ATP-binding cassette transporters.

Authors:  Marcin Kolaczkowski; Anna Kolaczkowska; Noboru Motohashi; Krystyna Michalak
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

Review 7.  Pharmacologic circumvention of multidrug resistance.

Authors:  J M Ford; W N Hait
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

8.  Membrane interactions of some catamphiphilic drugs and relation to their multidrug-resistance-reversing ability.

Authors:  I K Pajeva; M Wiese; H P Cordes; J K Seydel
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

9.  In silico structure-based screening of versatile P-glycoprotein inhibitors using polynomial empirical scoring functions.

Authors:  Sergey Shityakov; Carola Förster
Journal:  Adv Appl Bioinform Chem       Date:  2014-03-24

10.  Effect of trifluoperazine on Tc-99m sestamibi uptake in patients with advanced nonsmall cell lung cancer.

Authors:  Ümmühan Abdülrezzak; Zeynep Erdoğan; Güler Silov; Ayşegül Özdal; Özgül Turhal
Journal:  Indian J Nucl Med       Date:  2016 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.